Effectiveness of cervical cancer screening in Iceland, 1964–2002: a study on trends in incidence and mortality and the effect of risk factors

References

• Miller AB, Chamberlain J, Day NE, Hakama M, Prorok PC. Report on working of the UICC project on evaluation of screening for cancer. Int J Cancer 1990; 46: 761–9
   PubMed Web of Science ®Google Scholar
• Coleman D, Day N, Dougas G, Farmery E, Lynge E, Philip J, et al. European guidelines for quality assurance in cervical cancer screening. Europe Against Cancer Programme. Eur J Cancer 1993; 29A(suppl. 4)S1–38
   PubMed Web of Science ®Google Scholar
• IARC. Cervix Cancer Screening. Recommendation for public health implementation and further research. IARC Handbooks of Cancer Prevention, Volume 10. IARC Press, Lyon 2005; 239–241
   Google Scholar
• Sigurdsson K. Trends in cervical intra-epithelial neoplasia in Iceland through 1995: evaluation of targeted age groups and screening intervals. Acta Obstet Gynecol Scand 1999; 78: 486–92
   PubMed Web of Science ®Google Scholar
• Sigurdsson K, Sigvaldason H. Longitudinal trends in cervical cytological lesions and the effect of risk factors. A thirty year overview. Acta Obstet Gynecol Scand. 2006;85:350–358.
   PubMed Web of Science ®Google Scholar
• Sigurdsson K, Sigvaldason H. Longitudinal trends in cervical histological lesions (CIN 2–3 + ). A twenty-five year overview. Acta Obstet Gynecol Scand. 2006;85:359–365.
   PubMed Web of Science ®Google Scholar
• Poulsen HE, Taylor CW, Sobin LH. Histological classification of female genital tract tumours. WHO International Histological Classification of Tumours. WHO, Geneva 1975; 25–6
   Google Scholar
• Disaia PJ, Morrow CP, Townsend DE. Staging and classification. Synopsis of Gynaecologic Oncology, EJ Quilliga. Wiley, New York 1975; 2–5
   Google Scholar
• Gebski V, Leung O, McNeil D, Linn D. (eds) SPIDA User's Manual, 6th ed. New South WalesAustralia: Statistical Computing Laboratory, Macquarie University, 1992.
   Google Scholar
• Day NE. The epidemiological basis for evaluating different screening policies. IARC Sci Publ 1986; 76: 199–212
   PubMedGoogle Scholar
• Hakama M, Louhivuori K. A screening programme for cervical cancer that worked. Cancer Surv 1988; 7: 403–16
   PubMedGoogle Scholar
• Miller AB. Principles of screening and of the evaluation of screening programmes. Screening for Cancer, AB Miller. Academic Press, Orlando 1985; 3–24
   Google Scholar
• Viikki M, Pukkala E, Hakama M. Risk of cervical cancer after a negative Pap smear. J Med Screen 1999; 6: 103–7
   PubMed Web of Science ®Google Scholar
• Antilla A, Pukkala E, Söderman B, Kallio M, Nieminen P, Hakama M. Effect of organised screening on cervical cancer incidence and mortality in Finland, 1963–1995: recent increase in cervical cancer incidence. Int J Cancer 1999; 83: 59–65
   PubMed Web of Science ®Google Scholar
• Laukkanen P, Koskela P, Pukkala E, Dillner J, Läärä E, Knekt P, et al. Time trends in incidence and prevalence of human papillomavirus type 6, 11 and 16 infections in Finland. J Gen Virol 2003; 84: 2105–9
   PubMed Web of Science ®Google Scholar
• Bender SS, Geirsson RT, Kosmen E. Trends in teenage fertility, abortion and pregnancy rates in Iceland compared with other Nordic countries, 1976–99. Acta Obstet Gynecol Scand 2003; 82: 38–47
   PubMed Web of Science ®Google Scholar
• Sigurdsson K, Adalsteinsson S, Tulinius H, Ragnarsson J. The value of screening as an approach to cervical cancer control in Iceland, 1964–1986. Int J Cancer 1989; 43: 1–5
   PubMed Web of Science ®Google Scholar
• Sigurdsson K. Effect of organized screening on the risk of cervical cancer. Evaluation of screening activity in Iceland, 1964–1991. Int J Cancer 1993; 54: 563–70
   PubMed Web of Science ®Google Scholar
• Sigurdsson K. The Icelandic and Nordic cervical screening programmes: trends in incidence and mortality rates through 1995. Acta Obstet Gynecol Scand 1999; 78: 478–85
   PubMed Web of Science ®Google Scholar
• Holoway P, Miller AB, Rohan T, To T. Natural history of dysplasia of the uterine cervix. J Natl Cancer Inst 1999; 91: 252–8
   PubMed Web of Science ®Google Scholar
• Vizcaino AP, Moreno V, Bosch FX, Munoz N, Barros-Dios XM, Parkin DM. International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas. Int J Cancer 1998; 75: 536–45
   PubMed Web of Science ®Google Scholar
• Chamberlain J. Reasons that some screening programmes fail to control cervical cancer. In: Hakama M, Miller AB, Day NE (eds) Screening for cancer of the uterine cervix. IARC Sci Publ 1986; 76: 161–8.
   Google Scholar
• Sigurdsson K. Quality assurance in cervical cancer screening: the Icelandic experience 1964–1993. Eur J Cancer 1995; 31A: 728–34
   PubMed Web of Science ®Google Scholar
• Cuzick J, Szarewski A, Cubie H, Hulman G, Kitchener H, Luesley D, et al. Management of women who test positive for high-risk types of human papillomavirus: the HART study. Lancet 2003; 362: 1871–6
   PubMed Web of Science ®Google Scholar
• Baay MFD, Weyler J, Vermorken JB. The value of human papillomavirus detection in primary cervical cancer screening. Eur J Gynaecol Oncol 2004; 6: 665–9
   Google Scholar